Form 4: Zomedica CFO Peter Donato Acquires 25,000 Shares of Common Stock
SEC Form 4 Filing
Zomedica Corp's CFO, Peter Donato, purchased 25,000 shares of the company's common stock at a price of $0.1519 per share on June 10, 2024.
Summary
- On June 10, 2024, Peter Donato, the Chief Financial Officer of Zomedica Corp., acquired 25,000 shares of the company's common stock.
- The purchase price was $0.1519 per share.
- Following the transaction, Donato directly owns 25,000 shares of Zomedica Corp.
Sentiment
Score: 6
Explanation: Neutral sentiment. The document simply reports an insider transaction. The CFO's purchase could be seen as a positive signal, but without further context, it's difficult to gauge the overall impact.
Positives
- The CFO's purchase of shares could be interpreted as a sign of confidence in the company's future prospects.
Industry Context
Insider transactions are closely monitored as they can provide insights into a company's performance and future prospects. It is common for executives to buy or sell shares of their own company.
Stakeholder Impact
- The transaction may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/10/2024 | Date of the transaction: Peter Donato acquired 25,000 shares of Zomedica Corp. common stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.